# ArmeoSenso - Reward

> **NCT02257125** · NA · TERMINATED · sponsor: **Cereneo AG** · enrollment: 38 (actual)

## Conditions studied

- Stroke

## Interventions

- **BEHAVIORAL:** high incentive
- **BEHAVIORAL:** low incentive

## Key facts

- **NCT ID:** NCT02257125
- **Lead sponsor:** Cereneo AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01-27
- **Primary completion:** 2019-10-28
- **Final completion:** 2019-10-28
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Stopped due to futility considerations:

Sample size calculations have assumed smaller effect sizes than considered relevant now.
- **Last updated:** 2020-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257125, "ArmeoSenso - Reward". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02257125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*